This document summarizes regulations relating to the import of cosmetics in India. It defines cosmetics and outlines what types are prohibited from import under the Drugs and Cosmetics Act, including those that are not of standard quality, misbranded, contain unsafe ingredients, or contain banned substances like hexachlorophene or mercury compounds. It also describes registration requirements for imported cosmetic products, listing 28 specific types that must meet Indian standards. Misbranded and spurious cosmetics are defined, and penalties are outlined for offenses like importing prohibited cosmetics or selling non-standard or misbranded products.
Regulatory provision related to manufacture of cosmeticManish Rajput
cosmetic, regulatory provision, schedule M, condition of licence, schedule U, prohibition of certain cosmetics, misbranded and spurious cosmetics, loan licence, offences and penalties,
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICSPV. Viji
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICS , IMPORTANCE OF LABELING , LABELING REQUIREMENTS , Common or generic name of the product. , Product function , Use instruction , Name & address of Manufacturer , Country of manufacture , Manufacture Date , Expiry date , Net Quantity , Retail Sale Price , Storage condition , Barcodes , Batch number , Warning or Caution if hazard exists , Manufacturing License Number , Ingredients , Registration Certificate Number (RCN) , Consumer Care Details , Using Stickers , Brown/Red or green dot , Not a standard pack size under Legal Metrology(Packaged commodities) Rules
Cosmetics regulatory: includes Regulatory provision relating to manufacture of cosmetics, Schedule M (II) of D & C rule 1945 deals with requirements for the factory premises for the manufacture of cosmetic, requirement of plant & equipment, conditions of licencing, regulatory provision on sale of cosmetics, loan licence, Regulatory provision relating to import of cosmetics, offences & penalties, List of amending Act and adaptation orders.
Regulatory provision related to manufacture of cosmeticManish Rajput
cosmetic, regulatory provision, schedule M, condition of licence, schedule U, prohibition of certain cosmetics, misbranded and spurious cosmetics, loan licence, offences and penalties,
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICSPV. Viji
INDIAN REGULATORY REQUIREMENTS FOR LABELING OF COSMETICS , IMPORTANCE OF LABELING , LABELING REQUIREMENTS , Common or generic name of the product. , Product function , Use instruction , Name & address of Manufacturer , Country of manufacture , Manufacture Date , Expiry date , Net Quantity , Retail Sale Price , Storage condition , Barcodes , Batch number , Warning or Caution if hazard exists , Manufacturing License Number , Ingredients , Registration Certificate Number (RCN) , Consumer Care Details , Using Stickers , Brown/Red or green dot , Not a standard pack size under Legal Metrology(Packaged commodities) Rules
Cosmetics regulatory: includes Regulatory provision relating to manufacture of cosmetics, Schedule M (II) of D & C rule 1945 deals with requirements for the factory premises for the manufacture of cosmetic, requirement of plant & equipment, conditions of licencing, regulatory provision on sale of cosmetics, loan licence, Regulatory provision relating to import of cosmetics, offences & penalties, List of amending Act and adaptation orders.
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETICSourav Mohanto
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC.
Minimum requirement of space, equipment and machinery for manufacturing of cosmetic have been prescribed under M II to the Drugs and Cosmetics Rule,1945
Review of guidelines for herbal cosmetics by COSMOSDev Jain
Review of guidelines for herbal cosmetics by
private bodies like cosmos with respect to preservatives,
emollients, foaming agents, emulsifiers and rheology modifiers.
Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics .Regulatory provisions relating to import of cosmetics ,Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics – Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties.
1. Structure of skin.
2. Skin relating problems :
a. Dry skin
b. Acne
c. Pigmentation
d. Prickly heat
e. Wrinkles
f. Body odour
3. Structure of hair.
4. Hair growth cycle.
cosmetics - regulatory : Regulatory provisions related to cosmetics PV. Viji
REGULATORY PROVISIONS RELATED TO COSMETICS , REGULATORY PROVISIONS RELATING TO IMPORT OF COSMETICS , Application for registration certification for import cosmetics , Grant of registration certificate , Standards for imported cosmetics , REGULATORY PROVISIONS RELATING TO MANUFACTURE OF COSMETICS , REQUIREMENTS OF FACTORY PREMISES FOR MANUFACTURE OF COSMETICS , LOAN LICENCE
Cosmetics – Biological aspects
Structure of skin
Functions of Skin
Skin relating problem like,
Dry skin
Acne
Pigmentation
Prickly heat
Wrinkles
Body odor
Structure of hair
Hair growth cycle
Problem associated with Hair
pharmacy, cosmetics, regulatory provisions related to manufacturing, import, sell and distribution of cosmetics as per drug and cosmetics act and rules 1940&1945
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETICSourav Mohanto
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC.
Minimum requirement of space, equipment and machinery for manufacturing of cosmetic have been prescribed under M II to the Drugs and Cosmetics Rule,1945
Review of guidelines for herbal cosmetics by COSMOSDev Jain
Review of guidelines for herbal cosmetics by
private bodies like cosmos with respect to preservatives,
emollients, foaming agents, emulsifiers and rheology modifiers.
Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics .Regulatory provisions relating to import of cosmetics ,Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics – Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties.
1. Structure of skin.
2. Skin relating problems :
a. Dry skin
b. Acne
c. Pigmentation
d. Prickly heat
e. Wrinkles
f. Body odour
3. Structure of hair.
4. Hair growth cycle.
cosmetics - regulatory : Regulatory provisions related to cosmetics PV. Viji
REGULATORY PROVISIONS RELATED TO COSMETICS , REGULATORY PROVISIONS RELATING TO IMPORT OF COSMETICS , Application for registration certification for import cosmetics , Grant of registration certificate , Standards for imported cosmetics , REGULATORY PROVISIONS RELATING TO MANUFACTURE OF COSMETICS , REQUIREMENTS OF FACTORY PREMISES FOR MANUFACTURE OF COSMETICS , LOAN LICENCE
Cosmetics – Biological aspects
Structure of skin
Functions of Skin
Skin relating problem like,
Dry skin
Acne
Pigmentation
Prickly heat
Wrinkles
Body odor
Structure of hair
Hair growth cycle
Problem associated with Hair
pharmacy, cosmetics, regulatory provisions related to manufacturing, import, sell and distribution of cosmetics as per drug and cosmetics act and rules 1940&1945
This presentation will give General overview about Indian Regulatory Requirements for cosmetics.
This ppt contains information about latest cosmetics rules 2020 and D& C Act 1940
Regulatory Prohivision M. Pharm (Pharmaceutics).pptxPrachi Pandey
Drug and Cosmetics Act, 1940, defined “cosmetics” as-
“Any article intended to be rubbed, poured sprinkled or sprayed on or intended into or applied to any part of the human body for cleansing, beautifying, promoting attractiveness & altering appearance, and includes any article intended for use as a components of cosmetics”.
- Generally, cosmetics consisting misbranded, spurious & adulterated cosmetics products.
Definition of cosmetics.
Regulation provision relating to manufacture of cosmetics
a. How to obtain license
b. Conditions of license
c. Regulatory provision on sale of cosmetics
d. Loan license
Offences and Penalties
It based on the regulatory provision used in the importation of cosmetics pharmaceutical products to the another country.
This is the brief description.
M Pharm Pharmacognosy Semester 2, HERBAL COSMETICS UNIT 1, Herbal/natural cosmetics, Classification &
Economic aspects. Regulatory Provisions relation to manufacture of cosmetics: -
License, GMP, offences & Penalties, Import & Export of
Herbal/natural cosmetics, Industries involved in the production of
Herbal/natural cosmetics.
The Cometic registration and Import registration process as per regulations in India. CliniExperts Services Pvt. Ltd. provides consultation services in Cosmetic Registration since the import registration of cosmetics came into existence and became mandatory. For further assistance or queries please contact us at contact@cliniexperts.com or visit our website www.cliniexperts.com
Import, manufacture, sale or distribution of cosmetics were not being regulated in India prior to year 1962. In early sixties, it became necessary to regulate import, manufacture and sale distribution of cosmetics due to prevalence of misbranded and/or spurious cosmetics. Cosmetic was brought within the purview of the Drugs Act and the name of the Act was changed to the Drugs & Cosmetics Act, 1940 (hereinafter referred to as the Act) by Act 21 of 1962. However, the implementation of these provisions came into effect only in mid sixties when rules relating to import and manufacture of cosmetics were framed by the Government of India in 1964. Thereafter, rules have been amended time to time to achieve the intended purpose. Salient regulatory provisions will form the subject matter of this chapter
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
2. COSMETICS
• Cosmetics are regulated under The Drug and Cosmetic Act (D
& C Act)1940 and The Rule in 1945 and the labeling
Declarations by Bureau of Indian Standards (BIS). BIS sets the
standards for cosmetics for the products listed under
Schedule 'S' of the Drugs and cosmetics Rules 1945s.
• According to D & C Act Cosmetic is define as the means any
article intended to be rubbed, poured, sprinkled or sprayed
on, or introduced into, or otherwise applied to, the human
body or any part thereof for cleansing, beautifying, promoting
attractiveness, or altering the appearance, and includes any
article intended for use as a component of cosmetic.
3. • Chapter III of Drug and Cosmetic Act deals with import of
Drug and Cosmetic. Now import of certain cosmetic is
prohibited under section 10 of the Act and rules 134A, 135,
135A of Drug and Cosmetic Rules 1945 they are:
• Any cosmetic which is not of standard quality,
• Any misbranded or spurious cosmetic,
• Any cosmetic containing any ingredient which may render
it unsafe or harmful for use under the directions indicated
or recommended,
• Any cosmetic the import of which is prohibited by rule,
• Any cosmetic containing hexachlorophene,
• Any cosmetic in which lead and arsenic compound has
been used for coloring purpose,
• Any cosmetic which contains mercury compound.
5. • As defined under Rule 21 of Drugs & Cosmetics Rules, 1945,
all cosmetic products imported for sale in India need to be
registered with licensing authority.
• Application for registration (Form-42) with required
documents, are submitted to Drugs Controller General (I),
CDSCO, FDA Bhavan, Kotla Road, New Delhi.
• This application will be accompanied by the fee specified
along with information and undertaking in Schedule D-III.
• Single application in Form 42 for any number of brands
manufactured at one or more locations by a single
manufacturer.
• Single registration certificate in Form 43 issued to a particular
applicant in respect of import of any number of brands
manufactured at one or more locations by a single
manufacturer.
6. • Skin powder
• Skin powder for infants
• Powder hair dye
• Tooth powder
• tooth paste
• Bindi
• Skin creams
• Hair oils
• Kumkum powder
• Shampoos, soap based
• Shampoos, synthetic detergent based
• hair creams
• Oxidation hair dyes, liquid
• Henna powder
• Cologne
• Nail polish
• Aftershave lotions
• Pomades & brilliantine
• Depilatories, chemical
• Shaving creams
• Cosmetic pencils
• Lipsticks
• Toilet soap
• Liquid toilet soap
• Baby toilet soap
• Transparent toilet soap
• Saving soap
• Lip salve
28 cosmetics have been placed under schedule “S” (standards for
cosmetics) to the rules and are required to comply with Indian
standards and these are:
7. • Misbranded and Spurious cosmetics have
been define in section 17-C and 17-D as
under:
Misbranded cosmetic:
• If it contain a color which is not prescribed,
• If it not labeled in the prescribed manner,
• if the label or container bears any statement
which is false or misleading in any particular.
8. Spurious Cosmetic:
• A cosmetic shall be deemed to be spurious when:
• If it imported under a name which belongs to
another cosmetic,
• If the label or container bears the name of an
individual or a company purporting to be the
manufacturer of the cosmetic which individual or
company is fictitious or does not exist, or
• If it purport to be the product of a manufacturer
of whom it is not truly a product.
9. • Rule 134 of D&C Act stipulates that no
cosmetic shall be imported which
• contains a coal tar color other than the one
prescribed in schedule ’Q’.
• Coal tar color used in cosmetics shall not
contain more than:
• 2ppm of arsenic calculated as arsenic trioxide,
• 20ppm of lead calculated as lead,
• 100ppm of heavy metals other than lead
calculated as the total of the respective
metals.
10. OFFENCES AND PENALTIES
Contravention in brief Penalty
Import of spurious cosmetic or cosmetic
containing any ingredient which harmful for
use.
Imprisonment for term of 3 years which may
extends to 5 years with fine of five thousand
rupees.
Import of cosmetic whose import is prohibited
under section 10-A
Imprisonment for term of 3 years which may
extends to 5 years with fine of five thousand
rupees.
Repeated offence of above two. Imprisonment for term of 5 years and fine
which
may extend to 10 thousand rupees.
Sale/manufacture of cosmetic which is not of
standard or misbranded cosmetic
Imprisonment for term of 3 years which may
extends to 5 years with fine of five thousand
rupees.
